The results showed that high expression of CXCL11 was associated with poor prognosis in patients with LGG, PAAD, and UVM; however, in patients with OV, SARC, and SKCM high CXCL11 expression was associated with better prognosis. Here, CXCL11 is linked to pancreatic adenocarcinoma.